"Quetiapine Fumarate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A dibenzothiazepine and ANTIPSYCHOTIC AGENT that targets the SEROTONIN 5-HT2 RECEPTOR; HISTAMINE H1 RECEPTOR, adrenergic alpha1 and alpha2 receptors, as well as the DOPAMINE D1 RECEPTOR and DOPAMINE D2 RECEPTOR. It is used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER and DEPRESSIVE DISORDER.
Descriptor ID |
D000069348
|
MeSH Number(s) |
D02.886.680.702.500.500 D03.633.300.276.500
|
Concept/Terms |
Quetiapine Fumarate- Quetiapine Fumarate
- Fumarate, Quetiapine
- Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (E)-2-butenedioate (2:1) (salt)
ICI 204,636- ICI 204,636
- 204,636, ICI
- ICI-204636
- ICI204636
- ICI 204636
- 204636, ICI
Quetiapine- Quetiapine
- 2-(2-(4-dibenzo(b,f)(1,4)thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol
|
Below are MeSH descriptors whose meaning is more general than "Quetiapine Fumarate".
Below are MeSH descriptors whose meaning is more specific than "Quetiapine Fumarate".
This graph shows the total number of publications written about "Quetiapine Fumarate" by people in this website by year, and whether "Quetiapine Fumarate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2005 | 0 | 1 | 1 |
2006 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Quetiapine Fumarate" by people in Profiles.
-
Agitation Management in Pediatric Males with Anti-N-Methyl-D-Aspartate Receptor Encephalitis. J Child Adolesc Psychopharmacol. 2016 12; 26(10):939-943.
-
Antipsychotic utilization in the intensive care unit and in transitions of care. J Crit Care. 2016 06; 33:119-24.
-
A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization. Schizophr Res. 2006 Jul; 85(1-3):254-65.
-
Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics. Int Psychogeriatr. 2005 Dec; 17(4):617-29.
-
Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims. Pharmacoepidemiol Drug Saf. 2005 Jun; 14(6):417-25.
-
Pharmacology of antipsychotics in the elderly: a focus on atypicals. J Am Geriatr Soc. 2004 Dec; 52(12 Suppl):S258-65.
-
Asymptomatic QTc prolongation associated with quetiapine fumarate overdose in a patient being treated with risperidone. Hum Exp Toxicol. 2001 Apr; 20(4):215-9.